Achieve Rapid TSA-Based Multiplexing with LabSat® Research

Unlike some of the existing multiplex approaches, such as nextgeneration sequencing, mPCR, or mass spectrometry, multiplex immunofluorescence – also referred to as fluorescent multiplex immunohistochemistry – provides an edge to understand the co-expression and spatial distribution of multiple targets without compromising the tissue integrity.

Tyramide Signal Amplification (TSA) is an immunostaining method designed for its high sensitivity, capable of detecting low expressed epitopes that generates precise and clear results. Tyramide is coupled to a fluorophore to generate a signal amplification. Via a reaction mediated by HRP (horseradish peroxidase) coupled with the secondary antibody (AbII), tyramide turns into its active conformation and covalently binds to tyrosine residues proximal to the target epitope.

Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Translational Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Webinar
Tired of Manual Staining? Meet the LabSat® Research Platform

| Sponsored by Epredia

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts